Alexander Kreze Matěj Homer Tereza Barešová Kristina Klemperová
10.1530/EO-22-0047
Endocr Oncol
2022 Sep 22;2(1):K21-K24.
durvolumab hypoparathyroidism immune checkpoint inhibitors immune-related adverse effects
CC BY
https://pubmed.ncbi.nlm.nih.gov/37435467/
Case Reports
PMC10259288
37435467
Hypoparathyroidism: an uncommon adverse effect of treatment with durvalumab
2022